Sale disclosed
George M. Milne Jr
Director
Common Stock
- Reported value
- $830.9K
- Reported price
- $27.6968 / share
Loading data…Scanning SEC filings…Checking Congress reports…Following the signal…
Amylyx Pharmaceuticals, Inc.
Last 30 daysNo qualifying insider buying. Sales: $3.78M by 6 insiders.
Showing the first 6 of 28 trades on this page.
Director
Common Stock
Chief Medical Officer
Common Stock
Chief Medical Officer
Common Stock
Chief Financial Officer
Common Stock
Chief Financial Officer
Common Stock
Chief Legal Officer
Common Stock
Chief Legal Officer
Common Stock
Co-Chief Executive Officer
Common Stock
Co-Chief Executive Officer
Common Stock
Co-Chief Executive Officer
Common Stock
Co-Chief Executive Officer
Common Stock
Director
Common Stock
Director
Common Stock
Director
Stock Option (right to buy)
Derivative security · not the ordinary share price.
This row records an option exercise or conversion. The derivative transaction price is separate from the exercise price; it is not the stock's market price. Its row value is not shown as another stock purchase.
Director
Stock Option (right to buy)
Derivative security · not the ordinary share price.
This row records an option exercise or conversion. The derivative transaction price is separate from the exercise price; it is not the stock's market price. Its row value is not shown as another stock purchase.
Chief Financial Officer
Common Stock
The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.
Co-Chief Executive Officer
Common Stock
The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.
Chief Legal Officer
Common Stock
The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.
Chief Medical Officer
Common Stock
The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.
Co-Chief Executive Officer
Common Stock
The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.
Chief Legal Officer
Common Stock
Chief Legal Officer
Common Stock
Director
Stock Option (right to buy)
Derivative security · not the ordinary share price.
The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.
Director
Stock Option (right to buy)
Derivative security · not the ordinary share price.
The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.
Director
Stock Option (right to buy)
Derivative security · not the ordinary share price.
The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.
Director
Stock Option (right to buy)
Derivative security · not the ordinary share price.
The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.
Director
Stock Option (right to buy)
Derivative security · not the ordinary share price.
The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.
Director
Common Stock
| Reporting insider | Security / transaction | Amount / price | Value | Traded / disclosed | Source |
|---|---|---|---|---|---|
| Director | Common StockSale10b5-1 | 30,000$27.70 / share | $830.9K | Oct 5Filed Oct 7 · 2d later | SEC filing |
| Chief Medical Officer | Common StockSale2 trades | 10,028avg $32.40 / share | $324.87K | Sep 10Filed Sep 14 · 4d later | 2 filings
|
| Chief Financial Officer | Common StockSale2 trades | 10,810avg $32.36 / share | $349.82K | Sep 10Filed Sep 14 · 4d later | 2 filings
|
| Chief Legal Officer | Common StockSale2 trades | 9,536avg $32.46 / share | $309.51K | Sep 10Filed Sep 14 · 4d later | 2 filings
|
| Co-Chief Executive Officer | Common StockSale2 trades | 30,464avg $32.18 / share | $980.26K | Sep 10Filed Sep 14 · 4d later | 2 filings
|
| Co-Chief Executive Officer | Common StockSale2 trades | 30,464avg $32.19 / share | $980.5K | Sep 10Filed Sep 14 · 4d later | 2 filings
|
| Director | Common StockOption exercise or conversion | 25,000$1.76 / share | $44K | Aug 31Filed Sep 2 · 2d later | SEC filing |
| Director | Common StockOption exercise or conversion | 25,000$5.05 / share | $126.25K | Aug 31Filed Sep 2 · 2d later | SEC filing |
| Director | Stock Option (right to buy)Option exercise or conversion | Derivative units25,000$1.76 exercise / conversion price | Not a separate purchase | Aug 31Filed Sep 2 · 2d later | SEC filing |
| Director | Stock Option (right to buy)Option exercise or conversion | Derivative units25,000$5.05 exercise / conversion price | Not a separate purchase | Aug 31Filed Sep 2 · 2d later | SEC filing |
| Chief Financial Officer | Common StockGrant or award | 22,807Award · no purchase price | Non-cash award | Aug 18Filed Aug 20 · 2d later | SEC filing |
| Co-Chief Executive Officer | Common StockGrant or award | 60,039Award · no purchase price | Non-cash award | Aug 18Filed Aug 20 · 2d later | SEC filing |
| Chief Legal Officer | Common StockGrant or award | 21,284Award · no purchase price | Non-cash award | Aug 18Filed Aug 20 · 2d later | SEC filing |
| Chief Medical Officer | Common StockGrant or award | 22,807Award · no purchase price | Non-cash award | Aug 18Filed Aug 20 · 2d later | SEC filing |
| Co-Chief Executive Officer | Common StockGrant or award | 60,039Award · no purchase price | Non-cash award | Aug 18Filed Aug 20 · 2d later | SEC filing |
| Chief Legal Officer | Common StockSale10b5-1 | 15,000$18.32 / share | $274.75K | Jul 9Filed Jul 13 · 4d later | SEC filing |
| Chief Legal Officer | Common StockSale10b5-1 | 15,000$17.61 / share | $264.12K | Jul 10Filed Jul 13 · 3d later | SEC filing |
| Director | Stock Option (right to buy)Grant or award | Derivative units24,372Award · no purchase price | Non-cash award | Jun 4Filed Jun 8 · 4d later | SEC filing |
| Director | Stock Option (right to buy)Grant or award | Derivative units24,372Award · no purchase price | Non-cash award | Jun 4Filed Jun 8 · 4d later | SEC filing |
| Director | Stock Option (right to buy)Grant or award | Derivative units24,372Award · no purchase price | Non-cash award | Jun 4Filed Jun 8 · 4d later | SEC filing |
| Director | Stock Option (right to buy)Grant or award | Derivative units24,372Award · no purchase price | Non-cash award | Jun 4Filed Jun 8 · 4d later | SEC filing |
| Director | Stock Option (right to buy)Grant or award | Derivative units24,372Award · no purchase price | Non-cash award | Jun 4Filed Jun 8 · 4d later | SEC filing |
| Director | Common StockPurchase | 3,800$13.51 / share | $51.34K | May 21Filed May 26 · 5d later | SEC filing |
This reflects the filings imported so far, not a complete trading history.
$12,834 of common-equity purchase value after transaction-age decay across 180 days.
1 distinct reporting-owner group(s). Joint rows count once; identity is not proof of discretion.
This score describes qualifying insider purchases at issuer level. Read the methodology
Open a transaction's SEC filing for the primary evidence. A code P may describe an open-market or private purchase; classification is not proof of intent.
Insider activity can have many explanations. Signal Strength is not a probability of profit or a recommendation to trade.